Marker Therapeutics Provides Updates of its Lead Clinical Programs
Go back to Marker Therapeutics Provides Updates of its Lead Clinical Programs| (NASDAQ: MRKR) | Delayed: 0.91 -0.05 (5.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.96 | 52 Week High | $ | |||
| Open | $0.95 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $0.87 | EPS | $ | |||
| Volume | 217,613 | |||||



